Laxxon Medical is a pharma-technology company pioneering cutting-edge 3D screen printing development and manufacturing solutions for the pharmaceutical industry. Laxxon was founded in 2017 by a team of medical and business professionals with 20+ years of experience in the pharmaceutical industry. Our highly skilled team provides comprehensive pharmaceutical services to pharmaceutical partners including R&D, IP, and regulatory services.

1. 3D Printing for Complex
Drug Delivery Systems

2. 3D printed medication has come far
and is now able to print customized
medication to specifically suit an
individual patient, all while
retaining the original intentions of
the drug and providing a better
experience for the patient.
The basis of this relies on how pills work. When
you swallow any tablet, it will dissolve in your
stomach and intestines at a predetermined rate.
However, different pills are designed to dissolve at
different rates depending on what type of pill
you're taking and for what reason.

3. Once the pill has been ingested, the ingredients
can begin to circulate throughout your body
(Pharmacokinetics Absorption), making their
way to your organs and tissues.
Drug molecules work by binding to different
receptors on cells, which trigger a specific
response (Pharmacokinetics Distribution).
The Four Stages of Pharmacokinetics

4. It's this ability to customize that makes
3D-printed medication so unique and
the benefits so great:
1
2
3D printing of pills can be done with
complicated structures, which will allow for
custom release rates and even printing pills
on demand to make dosages more patient-
specific.
3D printing can print complicated
structures that will promote drug
absorption or a reduction in negative
side-effects from drug reactions.

5. Laxxon Medical's patented 3D
screen printing technology (SPID®
Technology) allows for the
heterogeneous distribution of active
pharmaceutical ingredients (APIs) in
any tablet or pill.
Production Printer EX432m

6. “
Heterogeneous distribution means that within our tablets, we are able to
control not only the amount and type of API or substance which is released
but also the time at which this substance is distributed in the body.
One particularly interesting element of heterogeneous distribution is the sequential release of actives.
For example, if a tablet contains more than one API, we can control different release times per API
based on the highly complex printed structures of our tablets. This is only possible through 3D screen
printing.
- Klaus Kühne, Laxxon Medical COO

7. For patients, heterogeneous
distribution and sequential release
provide several clinical benefits.
These include longer-lasting effects,
reduced side effects, and fewer
dosages.

8. Innovate With Us